Kiora Pharmaceuticals (KPRX) Earnings Date, Estimates & Call Transcripts $3.52 -0.04 (-1.12%) (As of 11/8/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Kiora Pharmaceuticals Latest Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 9) -$0.53 Beat By $0.42 Consensus EPS (Aug. 9) -$0.95 Kiora Pharmaceuticals released Q2 2024 earnings on August 9, 2024, reporting an EPS of -$0.53, which beat analysts' consensus estimates of -$0.95 by $0.42. Quarterly revenue was reported to be $0.02 million. With a trailing EPS of $0.00, Kiora Pharmaceuticals' earnings are expected to decrease next year, from $1.17 to ($2.23) per share. KPRX Upcoming EarningsKiora Pharmaceuticals' next earnings date is estimated for Thursday, November 14, 2024, based off prior year's reporting schedules. Get Kiora Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kiora Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataKPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KPRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Kiora Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.24-$0.24-$0.24Q2 20241-$0.95-$0.95-$0.95Q3 20241-$0.66-$0.66-$0.66Q4 20241-$0.65-$0.65-$0.65FY 20244-$2.50-$2.50-$2.50Q1 20251-$0.67-$0.67-$0.67Q2 20251-$0.66-$0.66-$0.66Q3 20251-$0.67-$0.67-$0.67Q4 20251-$0.67-$0.67-$0.67FY 20254($2.67)($2.67)($2.67) Kiora Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/9/2024--$0.95-$0.53+$0.42-$0.53-$0.02M5/10/2024Q1 2024$5.58$3.42 -$2.16$0.38$16.00M$16.00M11/9/2023Q3 2023-$2.70-$8.01 -$5.31-$0.89--8/8/2023Q2 2023-$4.59-$7.11 -$2.52-$0.79--5/9/2023Q1 2023-$15.75-$9.00+$6.75-$1.00--11/9/2022Q3 2022--$39.15 -$39.15-$2.67-- Get the Latest News and Ratings for KPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Kiora Pharmaceuticals Earnings - Frequently Asked Questions When is Kiora Pharmaceuticals's earnings date? Kiora Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on KPRX's earnings history. Did Kiora Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Kiora Pharmaceuticals (NASDAQ:KPRX) reported ($0.53) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.95) by $0.42. Learn more on analysts' earnings estimate vs. KPRX's actual earnings. How much revenue does Kiora Pharmaceuticals generate each year? Kiora Pharmaceuticals (NASDAQ:KPRX) has a recorded annual revenue of $16 million. How much profit does Kiora Pharmaceuticals generate each year? Kiora Pharmaceuticals (NASDAQ:KPRX) has a recorded net income of -$12.51 million. KPRX has generated $0.00 earnings per share over the last four quarters. What is Kiora Pharmaceuticals's EPS forecast for next year? Kiora Pharmaceuticals's earnings are expected to decrease from $1.17 per share to ($2.23) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies PRPH Earnings Date CLNN Earnings Date PASG Earnings Date CALC Earnings Date NXTC Earnings Date LUMO Earnings Date LEXX Earnings Date LTRN Earnings Date SRZN Earnings Date BLRX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW This page (NASDAQ:KPRX) was last updated on 11/8/2024 by MarketBeat.com Staff From Our Partners“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI Got FiredStarting off with a few hundred bucks, it wasn't long before I started generating $1,000 a day. Then $10,00...Opportunistic Trader | SponsoredCan Trump Make Housing Great Again?Trump won. But can he undo the damage the Democrats have inflicted on this nation? Under Biden, inflatio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
